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A new online tool, HEDIS by 
Geography, tracks the quality  
of care and health care resource 
use in California—and displays 
them by ZIP code and product 
line. The results graphically 
pinpoint areas to target for 
improvement.
Extensive information is available on the quality performance of health plans and phy-
sician organizations in California. The Office of the Patient Advocate (OPA) has report 
cards for HMO and PPO health plans and medical groups serving HMO patients. In 
2015, OPA will add Medicare Advantage to its medical group report card. In addition, 
California’s Department of Health Care Services maintains a Medi-Cal Managed Care 
Performance Dashboard tracking the quality, resource use and satisfaction levels with 
the state’s health plans. While essential for informing providers in quality improve-
ment efforts and consumers in decision-making, this information does not paint a 
clear picture of population health by geographic region. 
This Issue Brief presents analyses of data available through the HEDIS by Geogra-
phy tool, accessible at https://hbg.iha.org. The tool allows users to display and com-
pare measures of both quality of care and use of health care resources throughout 
California. Rates can be displayed by product line and geographic area—from as 
granular as a ZIP code to as extensive as statewide averages. 
Two main themes are highlighted in this brief:
Health plan products that rely primarily on integrated care delivery networks, 
such as HMOs and Medicare Advantage, generally have higher quality scores 
without using more resources. Analysis reveals higher quality scores in Commer-
cial HMOs compared to Commercial PPOs, and data suggest lower resource use 
rates in Medicare Advantage compared to Medicare fee-for-service (FFS). 
Resource use and health care quality vary widely throughout the state. The 
data collected and displayed highlight substantial variation within single measures 
across geographic areas in California. 
Data on the website cover about 19 million Californians, nearly half of the state’s to-
tal population. Eleven health plans participated in this project, contributing data across 
all of their product lines. Exhibit 1 shows enrollment for each product line available 
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ABOUT THIS ISSUE BRIEF
In May 2015, the Integrated Healthcare Association (IHA) launched an interactive 
online tool that displays Healthcare Effectiveness Data and Information Set (HEDIS) 
data by various geographic units. The tool, available at https://hbg.iha.org, tracks 
clinical measurements for the priority health conditions of cancer, diabetes and 
asthma. It also displays data summarizing quality of care and resource use as filtered 
by product line.
This Issue Brief presents highlights of data available through the HEDIS by Geogra-
phy tool—with particular concentration on what products offered the highest quality, 
as well as variation in quality measures tracked by geographic area.
2indicates more people receiving care in line with optimal 
clinical guidelines. For example, of the population included 
in HEDIS by Geography, 84.5% of the Commercial HMO 
women ages 50-74 met clinical guidelines for breast cancer 
screening and received a mammogram. In comparison, 
only 69.7 percent of similar Commercial PPO patients 
were screened for breast cancer. If the 4.6 million PPO 
enrollees represented by these data had been appropri-
ately screened for breast cancer at the same rate as those 
in HMOs, 55,356 more California women would have 
received mammograms in 2013.
PPO average quality scores trailed those of HMOs 
by 11 to 46 percentage points, with the sole exception of 
the measure of Medication Management for People with 
Asthma, for which the Commercial PPO rate was a few 
points higher than the HMO rate. 
In some cases, there is a dramatic spread. However, 
the largest gap, in Blood Sugar Control for People with 
Diabetes, may be at least partially due to data availabil-
ity, as it requires that lab results data be received by the 
plan and matched with the correct patient; the other 
measures are taken directly from claims and encounter 
data—the equivalent of a bill sent from the physician to 
the plan after services are rendered. 
The difference in Colorectal Cancer Screening rates is 
also large: 24 percentage points. By way of illustration, 
197,385 more PPO enrollees represented by these data 
would have to receive a colorectal cancer screening to 
make the two rates equal.
Exhibit 2 shows the average result for each of the six 
clinical quality measures tracked in HEDIS by Geogra-
phy, by product line.
Strong performance in Medicare HMO
Medicare Advantage, the HMO product line available 
to Medicare enrollees as an alternative to obtaining care 
in the market on a fee-for-service basis, had the highest 
average quality scores compared with the other product 
lines. Statewide averages were highest for every reported 
clinical quality measure.
on the HEDIS by Geography tool, as well as the approxi-
mate proportion of statewide enrollment represented by 
the data; data on fee-for-service Medi-Cal and Medicare 
are not included, nor is the uninsured population. Appen-
dix A lists the plans that contributed data, and provides 
details on the methodology. Appendix B provides infor-
mation about the six clinical quality and three resource use 
measures analyzed in this brief, as well as a comprehensive 
user's guide to the tool.
A note on limitations of the analysis:  the results pre-
sented here are descriptive. Adjustments were not made for 
the characteristics of the patient population or availability 
of medical services in a geographic area. While such adjust-
ments may be appropriate and useful in some cases, partic-
ularly for resource use measures, the objective of this Issue 
Brief was simply to present observed rates of clinical qual-
ity and resource use for key measures. Data presented here 
represent care delivered during 2013, before full implemen-
tation of the Affordable Care Act—including the expansion 
of Medi-Cal and launch of Covered California, the state’s 
health benefit exchange. As previously uninsured patients 
enroll in Medi-Cal and Covered California products, future 
updates to the data may reveal different results.  
CLINICAL QUALITY BY PRODUCT LINE
Commercial HMOs outperform Commercial PPOs
Commercial HMOs outperformed Commercial PPOs 
on five of the six clinical quality measures that HEDIS 
by Geography tracks. The results reflect the number of pa-
tients who received appropriate care; a higher percentage 
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Exhibit 1:  Product Lines and Enrollment,  
HEDIS by Geography (2013 data)
Commercial HMO
Commercial PPO
Medicare Advantage
Managed Medi-Cal 
Total 
Product Line
8,512,070
4,653,804
1,650,563
4,107,006
18,923,443
≈ 80%
≈ 50%
≈ 85%
≈ 70%
HEDIS by 
Geography 
Enrollment
% of Total  
Enrollment  
in CA
Sources: Total Enrollment in CA data gathered from the California 
HealthCare Foundation (http://www.chcf.org/), the Kaiser Family Foun-
dation (http://kff.org/), the California Department of Health Care Servic-
es (http://www.dhcs.ca.gov) and the California Department of Managed 
Health Care (https://www.dmhc.ca.gov/). Percentages are approximate.
”If the PPO enrollees had been appropriately 
screened for breast cancer at the same rate as 
those in HMOs, 55,356 more California women 
would have received mammograms in 2013.”
3For example, the average rates for Breast Cancer 
Screening by population were:
▪	86.8 percent in Medicare Advantage
▪	84.5 percent in Commercial HMO
▪	69.7 percent in Commercial PPO, and 
▪	57.4 percent in Managed Medi-Cal.
Medi-Cal quality scores low
Managed Medi-Cal clinical quality scores were lower than 
the managed Commercial and managed Medicare rates 
for all clinical quality measures included here. (Colorectal 
Cancer Screening is not measured in the Medi-Cal popu-
lation, as it is only recommended for patients over 50.)
However, managed Medi-Cal rates were higher than 
Commercial PPO for diabetes care—for both Blood 
Sugar Control and Kidney Disease Monitoring mea-
sures. In general, the patient population covered by 
Medi-Cal is considered more complex, and is lower 
income, than Commercial PPO enrollees. Accordingly, 
it is somewhat surprising that the Medi-Cal managed 
care plans show stronger results than the Commercial 
PPO plans on several quality measures. 
Data presented here represent care delivered during 
2013, before the Medi-Cal expansion in California.
RESOURCE USE BY PRODUCT LINE
The HEDIS by Geography tool also tracks resource use 
across ZIP codes in California by product line. For the 
Emergency Department (ED) Visits and Inpatient Bed 
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Days measures, results are presented per thousand mem-
ber years (PTMY). The Readmissions measure reports 
the percent of hospital admissions resulting in a readmis-
sion within 30 days. Resource Use results are presented 
by product line in Exhibit 3. Unlike quality measures, 
where a higher score indicates more patients receiving 
clinically appropriate care, there is no ideal level of re-
source use. However, trends in health care indicate sub-
stantial overuse of services, and lower rates can indicate 
that care is coordinated more efficiently. 
Managed Medi-Cal utilization high
The Medi-Cal population had some of the highest utiliza-
tion rates, driven largely by the high need SPD population 
(Seniors and Persons with Disabilities). The SPD average 
rate of Readmissions was 16.4 percent, while the non-SPD 
average was 8.7 percent, similar to the Commercial 
HMO and PPO rate of 8.1 percent. The same pattern 
was seen for Inpatient Bed Days, where the non-SPD 
rate was similar to the Commercial rates, but the SPD 
rate was significantly higher.
For ED Visits, however, both the SPD average of 
392.4 and non-SPD average of 421.5 were much higher 
than Commercial HMO and PPO product lines (159.3 
and 116.3, respectively), and even topped the Medicare 
Advantage ED visit average (372.3). Higher use of emer-
gency department services among the Medi-Cal popu-
lation is not surprising, but the extent of the difference 
raises questions about what is driving the utilization and 
how it might be more effectively managed. 
Exhibit 2:  Clinical Quality Measures by Product Line
Breast Cancer Screening
Colorectal Cancer Screening
Blood Sugar Control for People  
with Diabetes
Blood Sugar Screening for People  
with Diabetes
Kidney Disease Monitoring for People  
with Diabetes
Medication Management for People  
with Asthma
Measure Name
84.5
71.1
70.3
91.6
90.1
40.1
All  
Products  
(%)
California Statewide Average 
Managed 
Medi-Cal   
(%)
Medicare  
Advantage    
(%)
Commercial 
PPO     
(%)
Commercial 
HMO     
(%)
69.7
47.5
24.5
80.7
70.7
44.1
86.8
79.4
77.9
95.0
95.8
N/A
57.4
N/A
42.9
78.3
79.8
35.4
80.7
67.1
62.4
89.3
87.5
39.7
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Commercial HMO and PPO resource  
utilization similar
The average Commercial HMO and PPO utilization 
rates statewide were almost identical for Readmissions 
and Inpatient Bed Days. Commercial HMO members 
had higher ED use than Commercial PPO members 
however; they visited the ED an average of 43 more 
times per thousand member years. The small difference 
between utilization rates in the Commercial HMO and 
PPO product lines is unexpected, given the perception 
that utilization in HMO products is managed more 
tightly than in PPO. 
Medicare Advantage utilization rates were signifi-
cantly higher than the Commercial product lines, which 
is expected given the greater complexity of the health 
care needs of the senior population. 
Medicare Advantage utilization lower than FFS
Unlike Commercial HMO and PPO, the difference between 
managed and unmanaged Medicare utilization rates was 
striking. Although the results came from different sources, 
the substantial difference in utilization rates—with Medi-
care Advantage rates only 55-65% of the Medicare FFS 
rates—indicates that there is likely a true difference in 
performance.  Selection bias may be contributing to the 
difference—that is, older people with more complex 
health conditions opting out of Medicare Advantage—
but lower utilization could also reflect effective popu-
lation health management by the Medicare Advantage 
health plans and their contracted providers.
GETTING A BOOST FROM THE STARS?
To encourage Medicare Advantage plans to provide qual-
ity care, the Affordable Care Act authorized Medicare to 
pay plans bonuses based on the program’s 5-star quality 
rating system. 
The Centers for Medicare and Medicaid Services (CMS) 
launched a three-year demonstration implemented in 2012, 
rewarding high scoring plans with bonus payments and the 
ability to market to beneficiaries. In addition, CMS reserves 
the right to terminate contracts with those plans that earn a 
rating below three stars for three consecutive years.
CMS uses quality measures focusing on areas such as 
managing long-term conditions, preventative care, mem-
ber experiences with drug plans and plans’ customer 
service. Like HEDIS by Geography, the CMS Medicare 
Stars program tracks breast and colorectal cancer 
screenings, diabetes blood sugar screening and control, 
and diabetes kidney disease monitoring, although it does 
not measure asthma medication management. 
Early analysis shows the performance incentives are 
working. The ratings CMS released for 2015 showed stable 
or improved performance in nearly 70 percent of the 46 
Medicare Parts C and D Star measures—seven of which 
improved by more than ½ Star from 2014 to 2015, and 13 
of which earned ratings above 4 Stars in 2015. These results 
are consistent with the HEDIS by Geography project find-
ings that Medicare Advantage plans provide high quality care.
While there is much room for improvement, the Stars 
data not only act as an incentive for plans to achieve bonus-
es—but importantly, will provide a way to monitor whether 
quality ratings and bonus payments foster better care and 
improved health outcomes for patients in the future.
Exhibit 3:  Resource Use Measures by Product Line
Readmissions  
(% of admissions)
ED Visits (PTMY)
Inpatient Bed Days  
(PTMY)
Measure Name
8.1
159.3
133.5
All  
Products  
California Statewide Average 
Managed Medi-Cal
Non-SPD     SPD  
Medicare  
Advantage    
Commercial 
PPO     
Commercial 
HMO     
8.7
421.5
121.5
Medicare  
FFS   
16.4
392.4
534.5
8.1
116.3
133.3
18.4
567
1,363
11.2
372.3
758.3
10.2
228.3
209.9
Abbreviations:  PTMY = Per Thousand Member Years; SPD = Seniors and Persons with Disabilities, a subset of the Medi-Cal population
Sources:  Medicare FFS data come from Medicare Geographic Variation Public Use Files, State/County Table—All Beneficiaries, 2013 at 
www.cms.gov; source for all other data is HEDIS by Geography. 
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CALIFORNIA IN A NATIONAL CONTEXT
California outperforms the nation as a whole on both 
clinical quality and resource use, based on comparison of 
HEDIS by Geography data to national averages reported by 
the National Committee for Quality Assurance (NCQA). 
At the national level, HEDIS measures follow the same 
patterns as those observed in HEDIS by Geography for 
California: Commercial HMO rates are higher than Com-
mercial PPO rates for every clinical quality measure 
except Medication Management for People with Asthma 
(see Exhibit 4).
But the quality differential between product lines in 
California is larger than the national differential. Commer-
cial HMO rates in California outperformed national rates 
for every measure except for Medication Management for 
People with Asthma, while California Commercial PPO 
rates were lower than national PPO rates for five of the six 
measures and about the same for the Breast Cancer Screen-
ing measure. One would expect California’s rates to be 
somewhat lower than national rates, simply because the 
national measurement rates use a process called “chart 
review” that allows data collectors to go back to a patient’s 
chart and find the information they need for the clinical 
quality measure, usually resulting in a higher score; by 
contrast, the California HEDIS by Geography rates rely 
purely on billing data. Therefore, the lower California PPO 
rates compared to national rates are not particularly sur-
prising, while the higher HMO rates indicate performance 
strong enough to overcome the disadvantage conferred by 
administrative-only data.  
Exhibit 5 shows national averages for Commercial 
HMO and PPO product lines for two of the resource use 
Exhibit 4:  Comparison of National and California Clinical Quality Measures
Breast Cancer Screening
Colorectal Cancer Screening
Blood Sugar Control for People  
with Diabetes
Blood Sugar Screening for People  
with Diabetes
Kidney Disease Monitoring for People  
with Diabetes
Medication Management for People  
with Asthma
Measure Name
73.7
62.9
69.3
89.6
83.8
46.8
California Average 
Commercial 
PPO (%)
Commercial 
HMO (%)
69.5
56.5
62.4
87.3
78.8
49.6
84.5
71.1
70.3
91.6
90.1
40.1
69.7
47.5
24.5
80.7
70.7
44.1
National Average 
Commercial 
PPO (%)
Commercial 
HMO (%)
Source for national data is NCQA Quality Compass, 2014 (reflects performance in 2013); source for California data is HEDIS by Geography.  
Exhibit 5:  Comparison of National and California Resource Use Measures
ED Visits (PTMY)
Inpatient Bed Days (PTMY)
Measure Name
191.5
180.1
California Average 
Commercial 
PPO
Commercial 
HMO 
178.7
170.2
159.3
133.5
116.3
133.3
National Average 
Commercial 
PPO (%)
Commercial 
HMO
Abbreviation: PTMY = Per Thousand Member Years
Notes:  Source for national data is NCQA Quality Compass, 2014 (reflects performance in 2013); source for California data is HEDIS by Geography. 
Readmissions are not included in the table because national data that is comparable to the HEDIS by Geography data is not available.
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measures tracked in HEDIS by Geography. Both Commer-
cial product lines in California have lower utilization of ED 
Visits and Inpatient Bed Days than the national average.
GEOGRAPHIC VARIATION ACROSS CALIFORNIA
The HEDIS by Geography tool highlights the variation in 
each of the three resource use measures—Readmissions, 
Emergency Department (ED) Visits and Inpatient Bed 
Days—presenting a graphic picture of the variations in 
both resource use and quality of care throughout the state.
Large variation in resource use measures  
by ZIP code
The 5th percentile of Readmissions is 4.9 percent: about 5 
percent of ZIP codes had a lower Readmission rate, and 95 
percent of ZIP codes had a higher Readmission rate. Re-
admissions are almost three times as high in the 95th per-
centile ZIP code compared to the 5th percentile ZIP code. 
The range is even larger for ED Visits and Inpatient 
Bed Days. The 95th percentile of ED Visits is about 3.5 
three times larger than the rate for the 5th percentile. 
For Inpatient Bed Days, the 95th percentile ZIP code rate 
was more than five times as large as the rate for the 5th 
percentile ZIP code. 
Exhibit 6 shows the 5th, 50th and 95th percentiles of 
the resource use measures across ZIP codes in California.
Exhibit 6:  Resource Use Across Zip Codes
Readmissions  
(% of admissions)
ED Visits (PTMY)
Inpatient Bed Days  
(PTMY)
Percentiles Across ZIP Codes
4.9
111.3
75.7
5th 50th 95th
9.9
193.9
195.4
14.1
385.4
412.9
Abbreviation: PTMY = Per Thousand Member Years
Exhibit 7:  ED Visit Rates: Lowest and Highest, by County
Santa Cruz
Sutter
Butte
Monterey
Glenn
Shasta
Santa Barbara
Colusa
Ventura
Santa Clara
10 Counties with Lowest Rates
1
2
3
4
5
6
7
8
9
10
Emergency Department Visits (PTMY)
County Rank Rate
108.0
121.6
128.5
134.2
136.0
147.7
147.9
149.5
154.3
156.1
Kings
Tulare
Stanislaus
San Bernardino
Madera
Imperial
Sacramento
Riverside
Fresno
Los Angeles
10 Counties with Highest Rates
58
57
56
55
54
53
52
51
50
49
County Rank Rate
353.5
348.0
347.3
325.9
302.6
301.2
290.1
265.8
265.3
244.5
Abbreviation: PTMY = Per Thousand Member Years
Exhibit 7 shows the 10 counties in the state with the 
highest and lowest rates for ED Visits, which vary signif-
icantly. Residents in Kings, the county with the highest 
ED use, visit the ED more than three times as frequently 
as residents in Santa Cruz.
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Exhibit 8 is a graphic depiction of the use of health 
care resources throughout the state. Blue counties indi-
cate counties with the lowest rates of ED Visits, while 
orange counties are those with the highest use.
Exhibit 8:  ED Visits, Counties with Highest  
and Lowest Rates
Counties with Lowest Rates
Counties with Highest Rates
Exhibit 9:  Variation in Clinical Quality Ratings by ZIP Code
Large variation in clinical quality measures  
by ZIP code
Exhibit 9 shows the minimum and maximum rates, as
well as the 25th, 50th, and 75th percentiles of the rates of 
clinical quality measures across ZIP codes in California. 
In general, the lowest quartiles have the largest ranges—
indicating there is more variation, and more room for 
improvement, among lower performing ZIP codes. 
Exhibit 10 shows the 10 highest and lowest perform-
ing counties in the state for Colorectal Cancer Screening. 
The rates vary significantly across counties. For example, 
the rate of screening in Modoc county trails that of 
Solano by a substantial 43 percentage points.  Since Medi-
Cal data are not available for colorectal cancer screening, 
the figures below represent the statewide averages across 
commercial HMO, commercial PPO, and Medicare 
Advantage product lines for participating health 
plans; see Table B-1 in Appendix B for a full listing of 
measures by product line. 
Quartile 4 (highest performing 25% of ZIP codes)
Quartile 3
Quartile 2
Quartile 1 (lowest performing 25% of ZIP codes)
Highest performing
25% of ZIP codes
50 percentile
Lowest performing  
25% of ZIP codes
8INtegRAteD HeAltHCARe ASSoCIAtIoN 
Exhibit 11 helps illustrate the quality of health care by 
county. Blue counties have the highest rates of Colorectal 
Cancer Screening; orange counties are those with the low-
est rates. The highest performing counties are centered in 
the greater Bay Area, while the lowest performers are in 
rural areas of North and Central California.
Exhibit 10: Colorectal Cancer Screening Rates, Highest to Lowest, by County
Solano
Contra Costa
Alameda
Marin
Sonoma
Napa
San Joaquin
San Mateo
San Francisco
Placer
10 Highest Performing Counties
1
2
3
4
5
6
7
8
9
10
Colorectal Cancer Screening
County Rank Rate (%)
76.4
74.3
74.2
73.9
72.4
72.1
71.6
71.6
71.4
71.1
Modoc
Mono
Plumas
Trinity
Glenn
Tehama
Lassen
Sierra
Inyo
Lake
10 Lowest Performing Counties
58
57
56
55
54
53
52
51
50
49
County Rank Rate (%)
33.5
39.6
39.9
43.0
43.1
43.6
44.2
45.0
45.6
45.9
Exhibit 11:  Colorectal Cancer Screening: 
Counties with Highest and Lowest Rates
Counties with Lowest Rates
Counties with Highest Rates
INSIGHTS GAINED
Aggregating and analyzing data on several clinical quality 
and resource use measures representing 19 million Cali-
fornians generated new insights based on product line 
and geography.
Viewing the data at the ZIP code level by product 
line reveals that commercial HMOs outperform com-
mercial PPOs on clinical quality, with similar resource 
use; national data reinforce the finding, showing similar 
results. Likewise, the significantly lower resource use rates 
for Medicare Advantage’s HMO products compared to 
Medicare FFS suggest a potential for savings based on 
reducing use of inpatient services; data on Medicare FFS 
quality ratings were not available.
Medi-Cal managed care shows lower quality and 
higher resource use for several measures in comparison 
with Commercial products.  In some cases, utilization 
is dramatically higher, especially for the SPD members. 
While not entirely surprising given that the Medi-Cal 
population is low-income and tends to be more com-
plex, the results nevertheless point to the potential for 
significant quality improvement and savings in Medi-
Cal. Moreover, the data pre-dates the expansion of 
Medi-Cal eligibility in California. Since Medi-Cal now 
covers nearly one-third of California’s population, the 
findings are even more salient—and urgent. 
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Analyzing quality and resource use measures through 
a geographic lens reveals wide variation across the state, 
with vast differences in clinical quality and resource 
use between the counties with the highest and lowest 
rates. Such large differences signify an opportunity 
for major improvements in the care provided to large 
segments of California’s population. 
Additional analyses, going beyond the results presented 
in this Issue Brief, will doubtless yield new insights. For 
example, geographic units representing hospital referral 
regions, hospital service areas and Covered California 
regions within California are all available for viewing on 
the interactive map at https://hbg.iha.org, and for 
analysis through the downloadable data. 
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the California HealthCare Foundation (CHCF). IHA’s 
HEDIS by Geography project team included Cayman 
Nava, who created the online mapping tool, https://hbg.
iha.org, and Brian Goodness and Ann Hardesty, who 
contributed to data collection and analysis. Barbara 
Kate Repa provided invaluable editing services. The 
project could not have been completed without the 
participation of the health plan partners, who contrib-
uted both data and time to this effort. The participating 
plans, the Department of Health Care Services, and Mari-
beth Shannon at CHCF reviewed a draft of the brief and 
provided valuable feedback.  
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APPENDIX A
Methodology for HEDIS by Geography 
In 2014, the Integrated Healthcare Association (IHA) recruited 11 health plans to participate in the project.
Exhibit A1:  Participating Health Plans, by Product Line
Anthem Blue Cross
Blue Shield of California
CalOptima
Health Net
Inland Empire Health Plan
Kaiser Permanente
L.A. Care Health Plan
San Francisco Health Plan
SCAN Health Plan
UnitedHealthcare
Western Health Advantage
X
X
X
X
X
X
Commercial 
PPO
Commercial 
HMO
X
X
X
X
X
X
X
X
X
X
X
X
X
Managed
Medi-Cal  
Medicare  
Advantage
X
X
X
X
X
X
X
Through a series of workgroup meetings with represen-
tatives from each plan, participants agreed on nine mea-
sures to report. Measures were chosen on the basis of 
clinical importance and applicability across product lines.
Only two of the measures, Asthma Medication Man-
agement and Colorectal Cancer Screening, are not re-
ported for all product lines. The Table in Appendix B 
below shows a complete list of measures by product line. 
The managed Medi-Cal plans reported additional 
breakdowns for the three resource use measures, al-
lowing for comparison of the utilization of Seniors 
and Persons with Disabilities (SPD population) to all 
other Medi-Cal members. 
Each health plan contributed numerator and denomi-
nator data by ZIP code reflecting 2013 results for the nine 
selected HEDIS measures for their Medi-Cal, Commercial 
HMO and PPO, and Medicare Advantage members in 
California. The Medi-Cal data is more localized, be-
cause Medi-Cal managed care plans operate only in 
certain counties. Only members in those counties—
and neighboring ones, if members cross county lines to 
seek care—are included in the Medi-Cal rates. 
Data provided was administrative-only for the entire 
member population; it was not a sample and there was 
no medical record review. Plans attributed members to 
a ZIP code based on their home address. One plan with 
statewide enrollment supplied data for the Medication 
Management for People with Asthma measure only in 
Southern California, due to data availability issues.
IHA aggregated the data across plans at the ZIP code 
level, and rolled the ZIP codes up to Hospital Service 
Area, Hospital Referral Region, County, Covered Califor-
nia Region (one of 19 regions established by the state for 
California’s public exchange) and statewide averages.
Rates displayed on the map and included in the export 
feature are suppressed if contributed by only one plan, or 
if the denominator of the aggregated rate is fewer than 30.
The demographic data displayed was downloaded at 
the ZIP code level from the Census Bureau website. It 
was collected in the 2012 American Community Survey. 
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APPENDIX B
User’s Guide to HEDIS by Geography 
In May 2015, the Integrated Healthcare Association (IHA) 
launched an interactive online map tool that allows users 
to access Healthcare Effectiveness Data and Information 
Set (HEDIS) data by various geographic units and by 
product line offered.
Ways to Access the Information
Accessible at https://hbg.iha.org, HEDIS by Geography 
allows users to display and compare both quality of care 
and use of health care resources throughout the state of 
California. Information can also be viewed on the demo-
graphics of the populations living there.
Geographical Views Included
Users can filter and view HEDIS data by specific geo-
graphical areas, including:
▪	Statewide
▪	County, and 
▪	ZIP code.
They can also see the data according to provider service 
area, including:
▪	Covered California Region
▪	Hospital Referral Region, and
▪	Hospital Service Area.
For each of these geographical views, users can also drill 
down to sort and view the data by specific product line, 
including:
▪	All Plans
▪	Commercial PPOs
▪	Commercial HMOs 
▪	Medicare Advantage, and
▪	Managed Medi-Cal.
Measurements Included
HEDIS by Geography illustrates the quality and use of 
the state’s health care resources by clinical and resource 
use measures.  Some demographic indicators, such as 
race, education level and primary language spoken, can 
also be displayed.
Display by Clinical Measures
The site includes clinical measurements involving cancer, 
diabetes and asthma—commonly considered core priority 
health conditions, and all with strong performance mea-
sures in place. 
The measurements included are:
▪	Breast Cancer Screening: Percentage of women ages 
50 to 74 years old who had one or more mammogram(s) 
to screen for breast cancer
▪ Colorectal Cancer Screening: Percentage of adults ages 
50 to 75 years old who had one or more screening(s) for 
colorectal cancer—including fecal occult blood tests, 
flexible sigmoidoscopies and colonoscopies
▪ Blood Sugar Control for People with Diabetes: 
Percentage of adults 18 to 75 years old with either 
Type 1 or Type 2 diabetes whose most recent HbA1c 
level is above 9% or who have not been tested dur-
ing the measurement year (This result is inverted so 
that a higher rate is better.)
▪ Blood Sugar Screening for People with Diabetes: 
Percentage of adults 18 to 75 years old with either 
Type 1 or Type 2 diabetes who have had an HbA1c 
test performed
▪ Kidney Disease Monitoring for People with Dia-
betes: Percentage of adults 18 to 75 years old with 
either Type 1 or Type 2 diabetes who had nephropa-
thy screening or evidence of nephropathy
▪ Medication Management for People with Asthma: 
Percentage of people with persistent asthma who 
remained on an asthma controller medication for at 
least 75% of their treatment period
All performance measures are for the year the care was 
delivered.
Display by Resource Use
Hospital Readmissions, Emergency Department (ED) 
Visits and Inpatient Bed Days, important indicators of 
resources used, as defined below, were also tracked in 
HEDIS by Geography.
All-Cause Readmissions: Percentage of acute inpatients 
ages 18 and older discharged and readmitted for any 
diagnosis within 30 days. An additional breakdown is 
available for Seniors and Persons with Disabilities who 
have Managed Medi-Cal coverage; their utilization is 
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usually much higher than the rest of the Medi-Cal-eligi-
ble population.
Emergency Department Visits: Overall rate of visits 
per thousand member years (PTMY). An additional 
breakdown is available for Seniors and Persons with 
Disabilities who have Managed Medi-Cal coverage. 
Inpatient Bed Days: Overall rate of all bed days asso-
ciated with acute inpatient care discharges, on a per 
thousand member year (PTMY) basis. For Medicare 
Advantage and Medi-Cal, members 18 and older are 
included. For Commercial HMOs and PPOs, members 
18-64 are included.
Display by Demographics
Users can view the HEDIS data according to the percent-
age of the population that is:
▪ Black or African American
▪ Asian
▪ Hispanic, and
▪ White.
And they can also sort it by the percentage of the popula-
tion who speaks:
▪ Asian or Pacific Island languages, and
▪ Spanish or Spanish Creole languages.
The populations can also be viewed according to:
▪ Median income, and 
▪ Educational attainment, defined as those with a 
high school degree or above.
Exhibit B1:  HEDIS by Geography: Measurements at a Glance
Breast Cancer Screening
Colorectal Cancer Screening
Blood Sugar Control for People  
with Diabetes
Blood Sugar Screening for People  
with Diabetes
Kidney Disease Monitoring for People  
with Diabetes
Medication Management for People  
with Asthma
All Cause Readmissions
Emergency Department Visits
Inpatient Bed Days
African American Population
Asian Languages
Asian Population
Educational Attainment 
Hispanic Population
Median Income
Spanish Language
White Population
Measure Name
X
X
X
X
X
X
X
X
Total  
Population
Medicare  
Advantage
Commercial 
PPO
Commercial 
HMO
Managed
Medi-Cal
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
Note: All clinical quality and resource use rates are calculated from numerators and denominators reported by the participating health plans. Demo-
graphic data is from the U.S. Census Bureau, American Community Survey, 2012: http://factfinder.census.gov/faces/nav/jsf/pages/download_center.xhtml
X
X
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X
X
X
X
X
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